Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M3541 with Palliative Radiotherapy in Solid Tumors
NCT03225105Phase 1Terminated
- Sponsor
- EMD Serono
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of M3541 in solid tumor (4 arms), sponsored by EMD Serono. Primary endpoint: Number of Participants With Dose Limiting Toxicities at 4 weeks. Started Sep 2017; status: terminated.
02
Drugs
M3541
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03225105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03225105.